Ravelcare Limited (BOM:544629)
India · Delayed Price · Currency is INR 105.25
0.00 (0.00%)
At close: Sep 10, 2026
Ravelcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 269.54 | 249.79 | 220.88 | 34.94 | 7.89 |
Other Revenue | - | - | -0 | - | - |
| 269.54 | 249.79 | 220.88 | 34.94 | 7.89 | |
Revenue Growth | 7.91% | 13.09% | 532.23% | 343.01% | 1046.28% |
Cost of Revenue | 71.79 | 60.37 | 73.39 | 10.31 | 2.46 |
Gross Profit | 197.76 | 189.42 | 147.49 | 24.63 | 5.43 |
Selling, General & Admin | 98.47 | 96.16 | 57.96 | 13.78 | 5.18 |
Other Operating Expenses | 28.68 | 25.13 | 23 | 5.76 | 2.42 |
Operating Expenses | 127.86 | 122.27 | 81.19 | 19.54 | 7.6 |
Operating Income | 69.9 | 67.15 | 66.3 | 5.09 | -2.18 |
Interest & Investment Income | 2.75 | 2.71 | 1.91 | - | - |
Other Non Operating Income (Expenses) | 0 | 0.02 | -0.12 | -0.03 | -0.07 |
EBT Excluding Unusual Items | 72.65 | 69.87 | 68.09 | 5.06 | -2.25 |
Gain (Loss) on Sale of Investments | -1.92 | 0.46 | - | - | - |
Other Unusual Items | - | - | - | - | -0 |
Pretax Income | 70.73 | 70.34 | 68.09 | 5.06 | -2.25 |
Income Tax Expense | 19.19 | 19.48 | 17.85 | 0.91 | 0.57 |
Net Income | 51.54 | 50.86 | 50.24 | 4.15 | -2.82 |
Net Income to Common | 51.54 | 50.86 | 50.24 | 4.15 | -2.82 |
Net Income Growth | 1.34% | 1.22% | 1109.75% | - | - |
Shares Outstanding (Basic) | 6 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 6 | 5 | 5 | 5 | 5 |
Shares Change | 11.98% | - | - | - | -0.01% |
EPS (Basic) | 9.20 | 10.16 | 10.04 | 0.83 | -0.56 |
EPS (Diluted) | 9.20 | 10.16 | 10.04 | 0.83 | -0.56 |
EPS Growth | -9.48% | 1.21% | 1109.75% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -199.7 | -32.22 | 61.97 | 9.91 | -4.1 |
Free Cash Flow Per Share | -35.63 | -6.44 | 12.38 | 1.98 | -0.82 |
Gross Margin | 73.37% | 75.83% | 66.77% | 70.49% | 68.82% |
Operating Margin | 25.93% | 26.88% | 30.02% | 14.57% | -27.61% |
Profit Margin | 19.12% | 20.36% | 22.75% | 11.89% | -35.75% |
Free Cash Flow Margin | -74.09% | -12.90% | 28.06% | 28.38% | -52.03% |
EBITDA | 70.61 | 68.13 | 66.53 | 5.1 | -2.17 |
EBITDA Margin | 26.20% | 27.28% | 30.12% | 14.59% | -27.56% |
D&A For EBITDA | 0.71 | 0.99 | 0.23 | 0.01 | 0 |
EBIT | 69.9 | 67.15 | 66.3 | 5.09 | -2.18 |
EBIT Margin | 25.93% | 26.88% | 30.02% | 14.57% | -27.61% |
Effective Tax Rate | 27.13% | 27.70% | 26.21% | 17.99% | - |
Revenue as Reported | 270.37 | 252.98 | 222.79 | 34.94 | 7.89 |
Advertising Expenses | 97.3 | 95.12 | - | - | - |